Kishiki et al reported a scoring system for a patient with incurable Stage IV colorectal cancer. The authors are from Kyorin University in Tokyo.
Patient selection: incurable Stage IV colorectal cancer
Parameters:
(1) modified Glasgow Prognostic Score (mGPS)
(2) serum CEA in ng/mL (µg/L)
CRP
Albumin
mGPS
>= 10 mg/L
< 35 g/L
2
>= 35 g/L
1
< 10 mg/L
NA
0
Serum CEA
Group
<= 50
> 50
any
3
where:
• For mGPS=2, the table shows CEA > 50. There is no entry for CEA <= 50.
Hazard Ratio
Median Cancer-Specific Survival (CSS)
70 months
23 months
9.1
8.3 months
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
